What specific patient instruction is given regarding fever or diarrhea that develops during anti-infective therapy?

Correct answer: To not treat the diarrhea without consulting a health care professional.

Explanation

Diarrhea that develops during antibiotic therapy can sometimes be a sign of a serious complication like CDAD. Using anti-diarrheal medication can worsen this condition by trapping toxins in the colon. Therefore, patients must be instructed to consult their provider before self-treating.

Other questions

Question 1

What is the primary action of anti-infective agents on pathogenic bacteria?

Question 2

According to the general information on anti-infectives, what is their effectiveness against viruses or fungi?

Question 3

What is a key precaution mentioned regarding the use of anti-infective agents to optimize therapy?

Question 4

What potential consequence is associated with the prolonged inappropriate use of broad-spectrum anti-infective agents?

Question 5

What is the recommended nursing implementation to maintain therapeutic serum drug levels of most anti-infectives?

Question 6

What critical instruction should be given to patients regarding the duration of their anti-infective medication course?

Question 7

What interaction occurs when penicillins and aminoglycosides are physically admixed?

Question 8

Which nursing assessment is crucial before initiating anti-infective therapy, particularly with penicillins or cephalosporins?

Question 9

What effect can probenecid have on penicillins and related compounds?

Question 10

What symptoms should be promptly reported to a health care professional as a potential sign of Clostridium difficile-associated diarrhea (CDAD)?

Question 11

What type of interaction is noted between extended-spectrum penicillins and anticoagulants?

Question 12

The absorption of fluoroquinolones may be decreased by the concurrent use of which substances?

Question 13

What is the primary contraindication for the use of any anti-infective agent?

Question 14

What is an important nursing action regarding specimen collection for culture and sensitivity (C&S)?

Question 15

What patient teaching is essential regarding signs of superinfection?

Question 16

How are anti-infectives categorized according to the 'General Action and Information' section?

Question 17

In which patient population does the text advise cautious use of anti-infectives?

Question 18

What is the potential interaction between highly protein-bound anti-infectives like sulfonamides and other highly bound drugs?

Question 19

If a patient taking an anti-infective develops fever and diarrhea, especially with stool containing pus, blood, or mucus, what should the patient be instructed to do?

Question 20

What is the effect of erythromycin and clarithromycin on the hepatic metabolism of other drugs?

Question 21

What is the rationale for assessing for Clostridium difficile-associated diarrhea (CDAD) in a patient on anti-infectives?

Question 22

Which nursing diagnosis is listed as a potential issue for patients taking anti-infectives?

Question 23

Besides anticoagulants, which other drug classes are mentioned as potentially having an increased risk of bleeding when used with extended-spectrum penicillins?

Question 24

For which patients might dosage modification of anti-infectives be required?

Question 25

What does the term 'bacteriostatic' mean in the context of anti-infective action?

Question 26

What does the term 'bactericidal' mean in the context of anti-infective action?

Question 27

What is a key purpose of anti-infective therapy in addition to treatment of active infections?

Question 28

What might be required for some infections in addition to anti-infective therapy?

Question 29

What does the term 'cross-sensitivity' imply in the context of anti-infective contraindications?

Question 31

Which of the following substances can decrease the absorption of fluoroquinolones?

Question 32

What is the consequence of the interaction between some cephalosporins and anticoagulants?

Question 33

Which nursing implication is most critical for patient safety during anti-infective therapy?

Question 34

What is the primary reason to use anti-infectives with caution in patients with hepatic insufficiency?

Question 35

What are the two potential nursing diagnoses related to patient understanding and adherence mentioned in the text?

Question 36

What type of anti-infective may displace or be displaced by other highly bound drugs?

Question 37

According to the nursing assessment guidelines, what should be monitored regarding a patient's bowel function during anti-infective therapy?

Question 38

What is the rationale for the implementation guideline to administer most anti-infectives around the clock?

Question 39

When is it permissible for a first dose of an anti-infective to be given in relation to receiving culture and sensitivity results?

Question 40

What is the classification of zinc salts in the context of drug interactions with fluoroquinolones?

Question 41

Which of the following drug classes is NOT mentioned as interacting with extended-spectrum penicillins to increase bleeding risk?

Question 42

What is the general use of anti-infectives as defined in the text?

Question 43

What does the text say about the subdivision of anti-infectives?

Question 44

Under the 'Precautions' section, what is described as 'desirable to optimize therapy'?

Question 45

What is the key nursing assessment before administering a penicillin or cephalosporin?

Question 46

What patient instruction is crucial for ensuring the effectiveness of anti-infective therapy?

Question 47

Which condition is NOT a reason to use anti-infectives cautiously, according to the 'Precautions' section?

Question 48

The interaction between which two drug classes should prompt a nurse to avoid physical admixing?

Question 49

What nursing diagnosis relates to the patient's role in following the medication plan?

Question 50

What is the consequence of failing to obtain specimens for culture and sensitivity prior to initiating anti-infective therapy?